The Institute Krems Bioanalytics is the contract research institute of the IMC Krems University of Applied Sciences, which has been offering state-of-the-art bioanalytical services in the fields of immunology, hematology and oncology since 2014.

We have a long-standing expertise in the development and validation of customised and GxP-compliant analytical assays for large molecules and vaccines. With our customised analytical methods, we accompany the different development phases of a drug under strict quality-assured specifications. In addition, the Institute Krems Bioanalytics develops complex cell-based assays for drug efficacy testing or biopotency characterisation for lot releases. 
Our current research focuses on the molecular characterisation of the human immune response using mass spectrometry. In addition, we are dedicated to the development of novel approaches to assess the immunogenicity of biomolecules and vaccines and cell-based assays for drug discovery.

The Institute Krems Bioanalytics is located at the Technology and Research Center in Krems, one of the technology-oriented business clusters in Austria. The Biotech Area Krems encompasses three universities and numerous companies specialising in biomedical sciences.

The institute's mission is to be a comprehensive provider of bioanalytical services. It develops state-of-the-art and GxP-compliant technologies for the analysis of samples, generates reliable scientific data, operates in full compliance with regulatory requirements and establishes strategic partnerships in innovative research areas.